NEO1 and central nervous system cancer: Together, our data demonstrated that Neogenin interacts with Merlin to inhibit tumor malignancy by obstructing EMT progress, and the lack of Neogenin/Merlin is associated with the poorest prognosis in CRC and glioma patients.